Join
Live feed
·
INSIDERFilingvia Quantisnow
Lexicon Pharmaceuticals Inc. logo

Director Artal Participations S.A R.L. was granted 41,290 units of Series B Convertible Preferred Stock (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LXRX (Lexicon Pharmaceuticals Inc.) and more on Quantisnow.

Director Artal Participations S.A R.L. was granted 41,290 units of Series B Convertible Preferred Stock (SEC Form 4) | Quantisnow